Non‐immunostimulatory nonviral vectors
暂无分享,去创建一个
[1] G. Molema,et al. In Vivo Characteristics of Cationic Liposomes as Delivery Vectors for Gene Therapy , 2002, Pharmaceutical Research.
[2] M. Rao. Effects of tetrandrine on cardiac and vascular remodeling. , 2002, Acta pharmacologica Sinica.
[3] J. Ruysschaert,et al. Free cationic liposomes inhibit the inflammatory response to cationic lipid-DNA complex injected intravenously and enhance its transfection efficiency. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.
[4] J. G. Smith,et al. Biodistribution of radiolabeled lipid-DNA complexes and DNA in mice. , 1998, Journal of pharmaceutical sciences.
[5] A. Bird. CpG-rich islands and the function of DNA methylation , 1986, Nature.
[6] Xianglin Shi,et al. Tetrandrine Inhibits Signal-Induced NF-κB Activation in Rat Alveolar Macrophages , 1997 .
[7] T. Niidome,et al. Gene Therapy Progress and Prospects: Nonviral vectors , 2002, Gene Therapy.
[8] G. Bishop,et al. CpG motifs in bacterial DNA trigger direct B-cell activation , 1995, Nature.
[9] Z. Li,et al. Efficient in vivo gene transfer by PCR amplified fragment with reduced inflammatory activity , 2001, Gene Therapy.
[10] D. Gill,et al. Towards gene therapy for cystic fibrosis: a clinical progress report , 1998, Gene Therapy.
[11] J. Nordstrom,et al. Cationic lipids enhance cytokine and cell influx levels in the lung following administration of plasmid: cationic lipid complexes. , 1998, Journal of immunology.
[12] M. Stedman,et al. Contribution of plasmid DNA to inflammation in the lung after administration of cationic lipid:pDNA complexes. , 1999, Human gene therapy.
[13] H. Wong,et al. Nuclear factor-kappaB as a therapeutic target in critical care medicine. , 2003, Critical care medicine.
[14] Y. Tan,et al. The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo. , 1999, Human gene therapy.
[15] C. L. Johnson,et al. Comprehensive analysis of the acute toxicities induced by systemic administration of cationic lipid:plasmid DNA complexes in mice. , 2000, Human gene therapy.
[16] A. Krieg,et al. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. , 1998, Journal of immunology.
[17] D. Richman,et al. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants , 1997, Nature Medicine.
[18] Seng H. Cheng,et al. Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.
[19] D. Pisetsky,et al. Induction of anti-double stranded DNA antibodies in normal mice by immunization with bacterial DNA. , 1989, Journal of immunology.
[20] M. Hashida,et al. Hepatic uptake and gene expression mechanisms following intravenous administration of plasmid DNA by conventional and hydrodynamics-based procedures. , 2001, The Journal of pharmacology and experimental therapeutics.
[21] P. Felgner,et al. Cationic liposome mediated transfection. , 1989, Proceedings of the Western Pharmacology Society.
[22] R. Scheule,et al. Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung. , 1997, Human gene therapy.
[23] Hector R. Wong,et al. Nuclear factor-κB as a therapeutic target in critical care medicine , 2003 .
[24] Z. Li,et al. Sequential injection of cationic liposome and plasmid DNA effectively transfects the lung with minimal inflammatory toxicity. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.
[25] F. Chen,et al. Tetrandrine inhibits signal-induced NF-kappa B activation in rat alveolar macrophages. , 1997, Biochemical and biophysical research communications.
[26] I. Zuhorn,et al. Interference of serum with lipoplex-cell interaction: modulation of intracellular processing. , 2002, Biochimica et biophysica acta.
[27] M. Hashida,et al. The role of tissue macrophages in the induction of proinflammatory cytokine production following intravenous injection of lipoplexes , 2002, Gene Therapy.
[28] K. Schulze-Osthoff,et al. The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB , 1996, The Journal of experimental medicine.
[29] S. Akira,et al. A Toll-like receptor recognizes bacterial DNA , 2000, Nature.
[30] Simon C Watkins,et al. Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors. , 1999, American journal of physiology. Lung cellular and molecular physiology.
[31] Feng Liu,et al. Development of non-viral vectors for systemic gene delivery. , 2002, Journal of controlled release : official journal of the Controlled Release Society.